Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.33 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26529581 | 0.90 | MAP4K4 (0.33) | MAP4K4NTRK1NTRK3NTRK2PGR | |
| SCHEMBL26529605 | 0.89 | MAP4K4 (0.35) | MAP4K4PGR | |
| SCHEMBL26529551 | 0.89 | NR3C1 (0.36) | GAANOTUM | |
| SCHEMBL26529607 | 0.88 | MAP4K4 (0.34) | MAP4K4NTRK1NTRK3NTRK2PGR | |
| SCHEMBL26529065 | 0.86 | TSHR (0.36) | MAP4K4PGRMPIALDH1A1SMN1; SMN2 | |
| SCHEMBL26529553 | 0.86 | MAP4K4 (0.38) | MAP4K4PGRALDH1A1 | |
| SCHEMBL26529010 | 0.86 | MAP4K4 (0.35) | MAP4K4NTRK1NTRK3NTRK2PGR | |
| SCHEMBL26528744 | 0.84 | TSHR (0.36) | MAP4K4NTRK1NTRK3NTRK2PGR | |
| SCHEMBL26529107 | 0.84 | MAPT (0.37) | MAP4K4PGRALDH1A1MEN1KMT2A | |
| SCHEMBL26528758 | 0.83 | HTR7 (0.36) | MAP4K4NTRK1NTRK3NTRK2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | MAP4K4 4467/4885NTRK1 1835/4885NTRK3 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.